Introduction: Africa harbors a disproportionate burden of disease when taking into account
the triple challenge caused by HIV/AIDS, tuberculosis (TB) and malaria, against a backdrop …

Breast cancer is the most frequent cause of cancer death in low-and middle-income
countries, in particular among sub-Saharan African women, where response to available …

Background: Pharmacogenetics has a potential for optimizing drug response and identifying
risk of toxicity for patients. Pharmacogenetics knowledge of healthcare professionals and the …

Over the past decade, pharmacogenetics (PGx) became an essential tool for personalized
medicine although its clinical implementation is still limited. We aimed to assess the current …

Pharmacogenomics are frequently considered in personalized medicine to maximize
therapeutic benefits and minimize adverse drug reactions. However, there is a movement …

In humans, like every other organism, there is huge interindividual variability, resulting in
approximately 3.5–5 million naturally occurring genomic variants observed per genome …

Introducción: la existencia de variaciones interindividuales en la respuesta a los
medicamentos es multifactorial e incluye la genética y el medio ambiente por tanto, en la …

The field of personalized medicine is currently broadening in scope in at least three crucial
dimensions. First, while genetics/genomics individual variability is an important aspect of …

Precision medicine, empowered by machine learning, has made substantial strides in
developed countries, yet its implementation in Ghana faces substantial challenges due to …

Sequencing the human genome, more than a decade ago, initiated the genomics era and
the promise of truly personalized medicine. However, much is still unknown about the …